Clinical trial
Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV +…
NCT00357188 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00357188 |
|---|---|
| Title | Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects |
| Official title | Open-Label, Multiple Dose Study to Determine the Relative Bioavailability of Atazanavir (ATV) 400 mg Administered With Ritonavir (RTV) and Efavirenz (EFV) Compared to Atazanavir 300 mg Administered With Ritonavir Alone in Healthy Subjects |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, Protease Inhibitor |
| Intervention type | Drug |
| Interventions | Atazanavir Sulphate + Ritonavir, Atazanavir Sulphate + Ritonavir + Efavirenz |
| Enrollment | 22 |
| Start date | Jul 1, 2006 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Jul 27, 2006 |
| Last update posted | Apr 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: